Month: June 2010

  •     By James DeGiulio — Graceway's Injunction and Nycomed's Dismissal Denied In Aldara Suit Graceway Pharmaceuticals' suit against Nycomed alleging infringement of a patent for skin lesion treatment Aldara continues to move forward, after a ruling denied both defendant Nycomed's motion for dismissal and plaintiff Graceway's motion for a preliminary injunction. Graceway filed suit in…

  •     By Juan Serrano — On June 18, 2010, a decree was published in the Federal Official Gazette, reforming several provisions of the Mexican IP law related to patent practice.  The main amendments are the following: a) The industrial application requirement for patentability was modified to include a need to demonstrate the possibility of "practical utility"…

  •     By Kevin E. Noonan — Our opinions are always (perhaps inevitably) informed by our experience.  And when our experience is limited, particularly when those limitations are coupled with passion, those limitations equally inform our opinions. These realities come to mind when reviewing a letter from two medical students in the journal Science in response…

  •     By Andrew Williams — Last month, in addition to Photocure ASA v. Kappos and Ortho-McNeil Pharmaceutical, Inc. v. Lupin Pharmaceuticals, Inc., the Federal Circuit completed the hat trick of patent term extension cases with Wyeth Holdings Corp. v. Sebelius.  In this case, the Court affirmed the statutory construction decision of the U.S. District Court…

  •     By Donald Zuhn — On Friday, the World Intellectual Property Organization (WIPO) announced that the member states of WIPO's Patent Cooperation Treaty (PCT) had endorsed a series of recommendations for enhancing the international patent system.  The announcement came at the conclusion of PCT Working Group discussions that took place from June 14-18, 2010.  WIPO…

  •     By Sarah Fendrick — On June 2, 2010, Sharon Barner, Deputy Director of the U.S. Patent and Trademark Office, and Boris Simonov, Director of the Russian Federal Service for Intellectual Property, Patents and Trademark (Rospatent), signed a Memorandum of Understanding (MOU) on comprehensive bilateral cooperation between the two Offices.  The MOU, which was announced…

  •     By Sherri Oslick — About Court Report:  Each week we will report briefly on recently filed biotech and pharma cases. Pfizer Inc. et al. v. Mylan Inc. et al.1:10-cv-00528; filed June 16, 2010 in the District Court of Delaware • Plaintiffs:  Pfizer Inc.; Pharmacia & Upjohn Co.; Pharmacia & Upjohn Co. LLC; Sugen Inc.;…

  • June 21-22, 2010 – Follow-on Biologics (American Conference Institute) – New York, NY June 20-22, 2010 – IP Business Congress (Intellectual Asset Management (IAM) magazine) – Munich, Germany June 23, 2010 – Regulatory and Intellectual Property Opportunities and Challenges for Life Science Companies Entering the U.S. Market (American Bar Association) – 12:00 – 1:30 PM…

  • Law Seminars International (LSI) will be offering a one-hour telebriefing entitled: "Molecular Pathology v. U.S. PTO on Gene Patents" on June 24, 2010 from 1:00-2:00 PM (EDT).  Elizabeth Howard of Orrick Herrington & Sutcliffe LLP will moderate a panel including Sandra Wells, VP and Chief IP Counsel at Affymetrix, and Hans Sauer, Deputy General Counsel…

  • Marcus evans will be holding its 3rd Annual Product and Pipeline Enhancement for Generics conference on "Navigating Regulatory Pathways and Patent Strategies to Ensure Market Sustainability" on June 28-30, 2010 in Washington, DC.  The conference will enable attendees to: • Achieve effective patent strategies and gain knowledge on the most recent cases regarding Hatch-Waxman litigation;•…